Company: G
Filing Date: 2025-05-06
Form Type: DEFA14A
Source: 0001140361-25-017548
Chunk: 0

Company: Genpact LTD
Filing Date: 2025-05-06
Form: DEFA14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

| Filed by the Registrant ☒ | Filed by a Party other than the Registrant☐ |

| Check the appropriate box: |                                                                                 |
| ☐                          | Preliminary Proxy Statement                                                     |
| ☐                          | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐                          | Definitive Proxy Statement                                                      |
| ☒                          | Definitive Additional Materials                                                 |
| ☐                          | Soliciting Material Pursuant to 240.14a-12                                      |

GENPACT LIMITED (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

| Payment of Filing Fee (Check all boxes that apply): |                                                                                                      |
| ☒                                                   | No fee required.                                                                                     |
| ☐                                                   | Fee paid previously with preliminary materials.                                                      |
| ☐                                                   | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

Genpact Limited Canon’s Court 22 Victoria Street Hamilton HM 12 Bermuda SUPPLEMENT TO THE PROXY STATEMENT FOR
THE ANNUAL GENERAL MEETING OF SHAREHOLDERS
TO BE HELD ON MAY 22, 2025 This Proxy Statement Supplement (“Supplement”) is being filed on May 6, 2025 to supplement information contained in the Definitive Proxy Statement filed by Genpact Limited (“Genpact” or the “Company”) with the U.S. Securities and Exchange Commission (the “SEC”) on April 9, 2025 (the “Proxy Statement”) and made available to the Company’s shareholders in connection with the solicitation of proxies on behalf of the Board of Directors of the Company for its 2025 Annual General Meeting of Shareholders (the “Annual Meeting”), to be held on May 22, 2025 at 12:00 PM (local time), at 521 Fifth Avenue, 14 th Floor, New York, NY 10175.The Company urges you to read the Proxy Statement and this Supplement in their entirety. Except as specifically supplemented by the information contained in this Supplement, all information set